<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02106975</url>
  </required_header>
  <id_info>
    <org_study_id>HM20000917</org_study_id>
    <secondary_id>1UM1HL116885-01</secondary_id>
    <nct_id>NCT02106975</nct_id>
  </id_info>
  <brief_title>Vitamin C Infusion for Treatment in Sepsis Induced Acute Lung Injury</brief_title>
  <acronym>CITRIS-ALI</acronym>
  <official_title>Vitamin C Infusion for Treatment in Sepsis Induced Acute Lung Injury</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Virginia Commonwealth University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Virginia Commonwealth University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hypothesis 1A: Vitamin C infusion will significantly attenuate sepsis-induced systemic organ
      failure as measured by Sequential Organ Failure Assessment (SOFA) score,

      Hypothesis 1B: Vitamin C infusion will attenuate sepsis-induced lung injury as assessed by
      the oxygenation index and the VE40

      Hypothesis 1C: Vitamin C infusion will attenuate biomarkers of inflammation (C-Reactive
      Protein, Procalcitonin), vascular injury (Thrombomodulin, Angiopoietin-2), alveolar
      epithelial injury (Receptor for Advanced Glycation Products), while inducing the onset of a
      fibrinolytic state (Tissue Factor Pathway Inhibitor).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Actual">January 8, 2018</completion_date>
  <primary_completion_date type="Actual">November 16, 2017</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Modified Change in Sequential Organ Failure Assessment (mSOFA) Score</measure>
    <time_frame>96 hours</time_frame>
    <description>mSOFA is a single score based on patient status of five different biological systems: respiratory, cardiovascular, coagulation, renal, and neurological. Scores range from 0 to 20 with higher scores indicated worse status.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>C-Reactive Protein at Study Hours 0, 48, 96, 168 When Compared to Placebo</measure>
    <time_frame>up to 168 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Thrombomodulin Protein at Study Hours 0, 48, 96, 168 When Compared to Placebo</measure>
    <time_frame>Up to 168 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Oxygenation Index (FiO2 x Mean Airway Pressure/PaO2) at Study Hour 0, 48, 96, 168 if Still Intubated in Ascorbate Infused Patient Compared to Placebo.</measure>
    <time_frame>Up to hour 168</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VE-40 (Vent RR x TV/Weight) x (PaCO2/40) at Study Hour 0, 48, 96, 168 if Still Intubated, in Ascorbate Infused Patient Compared to Placebo</measure>
    <time_frame>Up to hour 168</time_frame>
    <description>Estimate of Shunt</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mSOFA Scores at Hours 0, 48, 96</measure>
    <time_frame>Up to hour 96</time_frame>
    <description>mSOFA is a single score based on patient status of five different biological systems: respiratory, cardiovascular, coagulation, renal, and neurological. Scores range from 0 to 20 with higher scores indicated worse status.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ascorbate Level at Hour 0, 48, 96, 168</measure>
    <time_frame>Up to hour 168</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ventilator Free Days to Day 28</measure>
    <time_frame>Up to Day 28</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU-free Days at Day 28</measure>
    <time_frame>Up to Day 28</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All Cause Mortality to Day 28</measure>
    <time_frame>Up to Day 28</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital-free Days at Day 60</measure>
    <time_frame>Up to Day 60</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procalcitonin at Study Hour 0, 48, 96, 168</measure>
    <time_frame>Up to hour 168</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Receptor for Advanced Glycation Endpoints at Study Hour 0, 48, 96, 168</measure>
    <time_frame>Up to hour 168</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tissue Factor Pathway Inhibitor at Study Hour 0, 48, 96, 168</measure>
    <time_frame>Up to hour 168</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxygenation Score: Pressure</measure>
    <time_frame>Up to hour 168</time_frame>
    <description>Oxygenation as measure by the ratio of arterial oxygen partial pressure to fractional inspired oxygen (PaO2/FiO2). Scores range from 100 to 300 with lower values indicating more worse outcomes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxygenation Score: Saturation</measure>
    <time_frame>Up to hour 168</time_frame>
    <description>Oxygenation as measure by the ratio of arterial oxygen saturation to fraction of inspired oxygen SpO2/FiO2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Coagulation</measure>
    <time_frame>Up to hour 168</time_frame>
    <description>Coagulation as measured by Platelets per unit of blood. Scores range from less than 20 to more than 150. Lower scores indicate worse outcomes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Liver Function</measure>
    <time_frame>Up to hour 168</time_frame>
    <description>Liver function as measured by Total Bilirubin. Normal levels range from 0.2 - 1.2. Levels greater than 1.2 indicate worse outcomes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular Function</measure>
    <time_frame>Up to hour 168</time_frame>
    <description>Cardiovascular function as measured by Mean arterial pressure. Scores less than 70 mmHg indicate worse outcomes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>State of Consciousness</measure>
    <time_frame>Up to hour 168</time_frame>
    <description>State of consciousness as measure by Glasgow Coma Scale which gives a score based on eye, verbal, and motor responses. Scores range from 3 to 15 with lower scores indicating worse outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Renal Function</measure>
    <time_frame>Up to hour 168</time_frame>
    <description>Renal function as measured by Creatinine. Scores range from less than 1.2 to greater than 5.0 with higher scores indicating worse outcomes</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">170</enrollment>
  <condition>Acute Lung Injury</condition>
  <condition>Sepsis</condition>
  <arm_group>
    <arm_group_label>Ascorbic Acid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>200mg/kg/day divided over 4 doses. Administered every 6 hours for 96 hours</description>
  </arm_group>
  <arm_group>
    <arm_group_label>5% Dextrose in Water</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>50ml every 6 hours for 96 hours</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ascorbic Acid</intervention_name>
    <description>Intervention</description>
    <arm_group_label>Ascorbic Acid</arm_group_label>
    <other_name>Vitamin C</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo: 5% Dextrose in water</intervention_name>
    <description>Placebo</description>
    <arm_group_label>5% Dextrose in Water</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients must have suspected or proven infection, and meet 2 out of 4 of the criteria
             for Systemic Inflammatory Response (SIRS) due to infection, and be accompanied by at
             least 1 criterion for sepsis-induced organ dysfunction, and meet all 5 criteria for
             Acute Respiratory Distress Syndrome (ARDS).

          -  Suspected or proven infection: (e.g., thorax, urinary tract, abdomen, skin, sinuses,
             central venous catheters, and central nervous system, see Appendix A).

          -  The presence of a systemic inflammatory response: Defined as: fever: &gt;38ºC (any route)
             or hypothermia: &lt;36ºC (core temp only), tachycardia: heart rate &gt; 90 beats/min or
             receiving medications that slow heart rate or paced rhythm, leukocytosis: &gt;12,000
             WBC/µL or leukopenia: &lt;4,000 WBC/µL or &gt;10% band forms. Respiratory rate &gt; 20 breaths
             per minute or PaCO2 &lt; 32 or invasive mechanical ventilation.

          -  The presence of sepsis associated organ dysfunction: (any of the following thought to
             be due to infection)

          -  Sepsis associated hypotension (systolic blood pressure (SBP) &lt; 90 mm Hg or an SBP
             decrease &gt; 40 mm Hg unexplained by other causes or use of vasopressors for blood
             pressure support (epinephrine, norepinephrine, dopamine =/&gt; 5mcg, phenylephrine,
             vasopressin)

          -  Arterial hypoxemia (PaO2/FiO2 &lt; 300) or supplemental O2 &gt; 6LPM.

          -  Lactate &gt; upper limits of normal laboratory results

          -  Urine output &lt; 0.5 ml/kg/hour for &gt; two hours despite adequate fluid resuscitation

          -  Platelet count &lt; 100,000 per mcL

          -  Coagulopathy (INR &gt; 1.5)

          -  Bilirubin &gt; 2 mg/dL

          -  Glasgow Coma Scale &lt; 11 or a positive CAM ICU score

          -  ARDS characterized by all the following criteria

          -  Lung injury of acute onset, within 1 week of an apparent clinical insult and with
             progression of respiratory symptoms

          -  Bilateral opacities on chest imaging not explained by other pulmonary pathology (e.g.
             pleural effusions, lung collapse, or nodules)

          -  Respiratory failure not explained by heart failure or volume overload

          -  Decreased arterial PaO2/FiO2 ratio ≤ 300 mm Hg

          -  Minimum PEEP of 5 cmH2O (may be delivered noninvasively with CPAP to diagnose mild
             ARDS

        Exclusion Criteria:

          -  Known allergy to Vitamin C

          -  inability to obtain consent;

          -  age &lt; 18 years;

          -  No indwelling venous or arterial catheter in patients requiring insulin in a manner
             that requires glucose being checked more than twice daily (e.g. continuous infusion,
             sliding scale);

          -  presence of diabetic ketoacidosis;

          -  more than 48 hrs since meeting ARDS criteria;

          -  patient or surrogate or physician not committed to full support (not excluded if
             patient would receive all supportive care except for cardiac resuscitation);

          -  pregnancy or breast feeding,

          -  moribund patient not expected to survive 24 hours;

          -  home mechanical ventilation (via tracheotomy or noninvasive) except for CPAP/BIPAP
             used only for sleep-disordered breathing;

          -  home O2 &gt; 2LPM, except for with CPAP/BIPAP

          -  diffuse alveolar hemorrhage (vasculitis);

          -  interstitial lung disease requiring continuous home oxygen therapy;

          -  Active kidney stone

          -  Non English speaking;

          -  Ward of the state (inmate, other)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alpha B. Fowler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Virginia Commonwealth University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Emory University and Grady Memorial Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Kentucky</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40506</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Virginia Commonwealth University Health System</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Froedtert and The Medical College of Wisconsin</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>March 27, 2014</study_first_submitted>
  <study_first_submitted_qc>April 3, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 8, 2014</study_first_posted>
  <results_first_submitted>June 28, 2019</results_first_submitted>
  <results_first_submitted_qc>October 14, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">October 15, 2019</results_first_posted>
  <disposition_first_submitted>March 7, 2019</disposition_first_submitted>
  <disposition_first_submitted_qc>March 7, 2019</disposition_first_submitted_qc>
  <disposition_first_posted type="Actual">March 12, 2019</disposition_first_posted>
  <last_update_submitted>October 14, 2019</last_update_submitted>
  <last_update_submitted_qc>October 14, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
    <mesh_term>Lung Injury</mesh_term>
    <mesh_term>Acute Lung Injury</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ascorbic Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>February 20, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/75/NCT02106975/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Ascorbic Acid</title>
          <description>200mg/kg/day divided over 4 doses. Administered every 6 hours for 96 hours
Ascorbic Acid: Intervention</description>
        </group>
        <group group_id="P2">
          <title>5% Dextrose in Water</title>
          <description>50ml every 6 hours for 96 hours
Placebo: 5% Dextrose in water: Placebo</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="84"/>
                <participants group_id="P2" count="83"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="59"/>
                <participants group_id="P2" count="44"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
                <participants group_id="P2" count="39"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
                <participants group_id="P2" count="39"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Ascorbic Acid</title>
          <description>200mg/kg/day divided over 4 doses. Administered every 6 hours for 96 hours
Ascorbic Acid: Intervention</description>
        </group>
        <group group_id="B2">
          <title>5% Dextrose in Water</title>
          <description>50ml every 6 hours for 96 hours
Placebo: 5% Dextrose in water: Placebo</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="84"/>
            <count group_id="B2" value="83"/>
            <count group_id="B3" value="167"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="54" lower_limit="39" upper_limit="67"/>
                    <measurement group_id="B2" value="57" lower_limit="44" upper_limit="70"/>
                    <measurement group_id="B3" value="56" lower_limit="41" upper_limit="68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="39"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="77"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="45"/>
                    <measurement group_id="B2" value="45"/>
                    <measurement group_id="B3" value="90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="82"/>
                    <measurement group_id="B2" value="81"/>
                    <measurement group_id="B3" value="163"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="32"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="68"/>
                    <measurement group_id="B2" value="60"/>
                    <measurement group_id="B3" value="128"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="84"/>
                    <measurement group_id="B2" value="83"/>
                    <measurement group_id="B3" value="167"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Modified Change in Sequential Organ Failure Assessment (mSOFA) Score</title>
        <description>mSOFA is a single score based on patient status of five different biological systems: respiratory, cardiovascular, coagulation, renal, and neurological. Scores range from 0 to 20 with higher scores indicated worse status.</description>
        <time_frame>96 hours</time_frame>
        <population>3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient</population>
        <group_list>
          <group group_id="O1">
            <title>Ascorbic Acid</title>
            <description>200mg/kg/day divided over 4 doses. Administered every 6 hours for 96 hours
Ascorbic Acid: Intervention</description>
          </group>
          <group group_id="O2">
            <title>5% Dextrose in Water</title>
            <description>50ml every 6 hours for 96 hours
Placebo: 5% Dextrose in water: Placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Modified Change in Sequential Organ Failure Assessment (mSOFA) Score</title>
          <description>mSOFA is a single score based on patient status of five different biological systems: respiratory, cardiovascular, coagulation, renal, and neurological. Scores range from 0 to 20 with higher scores indicated worse status.</description>
          <population>3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="84"/>
                <count group_id="O2" value="83"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.96" spread="4.20"/>
                    <measurement group_id="O2" value="-3.20" spread="3.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>C-Reactive Protein at Study Hours 0, 48, 96, 168 When Compared to Placebo</title>
        <time_frame>up to 168 hours</time_frame>
        <population>3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient</population>
        <group_list>
          <group group_id="O1">
            <title>Ascorbic Acid</title>
            <description>200mg/kg/day divided over 4 doses. Administered every 6 hours for 96 hours
Ascorbic Acid: Intervention</description>
          </group>
          <group group_id="O2">
            <title>5% Dextrose in Water</title>
            <description>50ml every 6 hours for 96 hours
Placebo: 5% Dextrose in water: Placebo</description>
          </group>
        </group_list>
        <measure>
          <title>C-Reactive Protein at Study Hours 0, 48, 96, 168 When Compared to Placebo</title>
          <population>3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient</population>
          <units>µg/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="84"/>
                <count group_id="O2" value="83"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>0 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="109" spread="76"/>
                    <measurement group_id="O2" value="119" spread="67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80" spread="66"/>
                    <measurement group_id="O2" value="84" spread="52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="56" spread="51"/>
                    <measurement group_id="O2" value="59" spread="52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>168 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54" spread="48"/>
                    <measurement group_id="O2" value="46" spread="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Thrombomodulin Protein at Study Hours 0, 48, 96, 168 When Compared to Placebo</title>
        <time_frame>Up to 168 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ascorbic Acid</title>
            <description>200mg/kg/day divided over 4 doses. Administered every 6 hours for 96 hours
Ascorbic Acid: Intervention</description>
          </group>
          <group group_id="O2">
            <title>5% Dextrose in Water</title>
            <description>50ml every 6 hours for 96 hours
Placebo: 5% Dextrose in water: Placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Thrombomodulin Protein at Study Hours 0, 48, 96, 168 When Compared to Placebo</title>
          <units>ng/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="84"/>
                <count group_id="O2" value="83"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>0 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14" spread="11"/>
                    <measurement group_id="O2" value="14" spread="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15" spread="11"/>
                    <measurement group_id="O2" value="15" spread="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15" spread="10"/>
                    <measurement group_id="O2" value="15" spread="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>168 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14" spread="9"/>
                    <measurement group_id="O2" value="14" spread="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Oxygenation Index (FiO2 x Mean Airway Pressure/PaO2) at Study Hour 0, 48, 96, 168 if Still Intubated in Ascorbate Infused Patient Compared to Placebo.</title>
        <time_frame>Up to hour 168</time_frame>
        <population>3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient</population>
        <group_list>
          <group group_id="O1">
            <title>Ascorbic Acid</title>
            <description>200mg/kg/day divided over 4 doses. Administered every 6 hours for 96 hours
Ascorbic Acid: Intervention</description>
          </group>
          <group group_id="O2">
            <title>5% Dextrose in Water</title>
            <description>50ml every 6 hours for 96 hours
Placebo: 5% Dextrose in water: Placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Oxygenation Index (FiO2 x Mean Airway Pressure/PaO2) at Study Hour 0, 48, 96, 168 if Still Intubated in Ascorbate Infused Patient Compared to Placebo.</title>
          <population>3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient</population>
          <units>Index</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="84"/>
                <count group_id="O2" value="83"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>0 hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11" spread="10"/>
                    <measurement group_id="O2" value="10" spread="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7" spread="5"/>
                    <measurement group_id="O2" value="7" spread="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9" spread="6"/>
                    <measurement group_id="O2" value="7" spread="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>168 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8" spread="8"/>
                    <measurement group_id="O2" value="8" spread="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>VE-40 (Vent RR x TV/Weight) x (PaCO2/40) at Study Hour 0, 48, 96, 168 if Still Intubated, in Ascorbate Infused Patient Compared to Placebo</title>
        <description>Estimate of Shunt</description>
        <time_frame>Up to hour 168</time_frame>
        <population>3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient</population>
        <group_list>
          <group group_id="O1">
            <title>Ascorbic Acid</title>
            <description>200mg/kg/day divided over 4 doses. Administered every 6 hours for 96 hours
Ascorbic Acid: Intervention</description>
          </group>
          <group group_id="O2">
            <title>5% Dextrose in Water</title>
            <description>50ml every 6 hours for 96 hours
Placebo: 5% Dextrose in water: Placebo</description>
          </group>
        </group_list>
        <measure>
          <title>VE-40 (Vent RR x TV/Weight) x (PaCO2/40) at Study Hour 0, 48, 96, 168 if Still Intubated, in Ascorbate Infused Patient Compared to Placebo</title>
          <description>Estimate of Shunt</description>
          <population>3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient</population>
          <units>mmMercury</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="84"/>
                <count group_id="O2" value="83"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>0 hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="127" spread="58"/>
                    <measurement group_id="O2" value="121" spread="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="127" spread="63"/>
                    <measurement group_id="O2" value="123" spread="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="127" spread="47"/>
                    <measurement group_id="O2" value="114" spread="46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>168 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="115" spread="54"/>
                    <measurement group_id="O2" value="131" spread="77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>mSOFA Scores at Hours 0, 48, 96</title>
        <description>mSOFA is a single score based on patient status of five different biological systems: respiratory, cardiovascular, coagulation, renal, and neurological. Scores range from 0 to 20 with higher scores indicated worse status.</description>
        <time_frame>Up to hour 96</time_frame>
        <population>3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient</population>
        <group_list>
          <group group_id="O1">
            <title>Ascorbic Acid</title>
            <description>200mg/kg/day divided over 4 doses. Administered every 6 hours for 96 hours
Ascorbic Acid: Intervention</description>
          </group>
          <group group_id="O2">
            <title>5% Dextrose in Water</title>
            <description>50ml every 6 hours for 96 hours
Placebo: 5% Dextrose in water: Placebo</description>
          </group>
        </group_list>
        <measure>
          <title>mSOFA Scores at Hours 0, 48, 96</title>
          <description>mSOFA is a single score based on patient status of five different biological systems: respiratory, cardiovascular, coagulation, renal, and neurological. Scores range from 0 to 20 with higher scores indicated worse status.</description>
          <population>3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient</population>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="84"/>
                <count group_id="O2" value="83"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>0 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10" lower_limit="7" upper_limit="12"/>
                    <measurement group_id="O2" value="10" lower_limit="8" upper_limit="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9" lower_limit="5" upper_limit="12"/>
                    <measurement group_id="O2" value="8" lower_limit="6" upper_limit="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6" lower_limit="4" upper_limit="10"/>
                    <measurement group_id="O2" value="6" lower_limit="5" upper_limit="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Ascorbate Level at Hour 0, 48, 96, 168</title>
        <time_frame>Up to hour 168</time_frame>
        <population>3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient</population>
        <group_list>
          <group group_id="O1">
            <title>Ascorbic Acid</title>
            <description>200mg/kg/day divided over 4 doses. Administered every 6 hours for 96 hours
Ascorbic Acid: Intervention</description>
          </group>
          <group group_id="O2">
            <title>5% Dextrose in Water</title>
            <description>50ml every 6 hours for 96 hours
Placebo: 5% Dextrose in water: Placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Ascorbate Level at Hour 0, 48, 96, 168</title>
          <population>3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient</population>
          <units>µM</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="84"/>
                <count group_id="O2" value="83"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>0 hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25" spread="18"/>
                    <measurement group_id="O2" value="26" spread="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="301" spread="355"/>
                    <measurement group_id="O2" value="24" spread="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="397" spread="580"/>
                    <measurement group_id="O2" value="26" spread="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>168 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90" spread="145"/>
                    <measurement group_id="O2" value="28" spread="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Ventilator Free Days to Day 28</title>
        <time_frame>Up to Day 28</time_frame>
        <population>3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient</population>
        <group_list>
          <group group_id="O1">
            <title>Ascorbic Acid</title>
            <description>200mg/kg/day divided over 4 doses. Administered every 6 hours for 96 hours
Ascorbic Acid: Intervention</description>
          </group>
          <group group_id="O2">
            <title>5% Dextrose in Water</title>
            <description>50ml every 6 hours for 96 hours
Placebo: 5% Dextrose in water: Placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Ventilator Free Days to Day 28</title>
          <population>3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient</population>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="84"/>
                <count group_id="O2" value="83"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13" spread="11"/>
                    <measurement group_id="O2" value="11" spread="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>ICU-free Days at Day 28</title>
        <time_frame>Up to Day 28</time_frame>
        <population>3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient</population>
        <group_list>
          <group group_id="O1">
            <title>Ascorbic Acid</title>
            <description>200mg/kg/day divided over 4 doses. Administered every 6 hours for 96 hours
Ascorbic Acid: Intervention</description>
          </group>
          <group group_id="O2">
            <title>5% Dextrose in Water</title>
            <description>50ml every 6 hours for 96 hours
Placebo: 5% Dextrose in water: Placebo</description>
          </group>
        </group_list>
        <measure>
          <title>ICU-free Days at Day 28</title>
          <population>3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient</population>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="84"/>
                <count group_id="O2" value="83"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11" spread="10"/>
                    <measurement group_id="O2" value="8" spread="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>All Cause Mortality to Day 28</title>
        <time_frame>Up to Day 28</time_frame>
        <population>3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient</population>
        <group_list>
          <group group_id="O1">
            <title>Ascorbic Acid</title>
            <description>200mg/kg/day divided over 4 doses. Administered every 6 hours for 96 hours
Ascorbic Acid: Intervention</description>
          </group>
          <group group_id="O2">
            <title>5% Dextrose in Water</title>
            <description>50ml every 6 hours for 96 hours
Placebo: 5% Dextrose in water: Placebo</description>
          </group>
        </group_list>
        <measure>
          <title>All Cause Mortality to Day 28</title>
          <population>3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="84"/>
                <count group_id="O2" value="83"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30"/>
                    <measurement group_id="O2" value="46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hospital-free Days at Day 60</title>
        <time_frame>Up to Day 60</time_frame>
        <population>3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient</population>
        <group_list>
          <group group_id="O1">
            <title>Ascorbic Acid</title>
            <description>200mg/kg/day divided over 4 doses. Administered every 6 hours for 96 hours
Ascorbic Acid: Intervention</description>
          </group>
          <group group_id="O2">
            <title>5% Dextrose in Water</title>
            <description>50ml every 6 hours for 96 hours
Placebo: 5% Dextrose in water: Placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Hospital-free Days at Day 60</title>
          <population>3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient</population>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="84"/>
                <count group_id="O2" value="83"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23" spread="22"/>
                    <measurement group_id="O2" value="15" spread="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Procalcitonin at Study Hour 0, 48, 96, 168</title>
        <time_frame>Up to hour 168</time_frame>
        <population>3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient</population>
        <group_list>
          <group group_id="O1">
            <title>Ascorbic Acid</title>
            <description>200mg/kg/day divided over 4 doses. Administered every 6 hours for 96 hours
Ascorbic Acid: Intervention</description>
          </group>
          <group group_id="O2">
            <title>5% Dextrose in Water</title>
            <description>50ml every 6 hours for 96 hours
Placebo: 5% Dextrose in water: Placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Procalcitonin at Study Hour 0, 48, 96, 168</title>
          <population>3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient</population>
          <units>ng/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="84"/>
                <count group_id="O2" value="83"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>0 hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12" spread="23"/>
                    <measurement group_id="O2" value="27" spread="69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7" spread="18"/>
                    <measurement group_id="O2" value="9" spread="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" spread="6"/>
                    <measurement group_id="O2" value="4" spread="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>168 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" spread="3"/>
                    <measurement group_id="O2" value="3" spread="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Receptor for Advanced Glycation Endpoints at Study Hour 0, 48, 96, 168</title>
        <time_frame>Up to hour 168</time_frame>
        <population>3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient</population>
        <group_list>
          <group group_id="O1">
            <title>Ascorbic Acid</title>
            <description>200mg/kg/day divided over 4 doses. Administered every 6 hours for 96 hours
Ascorbic Acid: Intervention</description>
          </group>
          <group group_id="O2">
            <title>5% Dextrose in Water</title>
            <description>50ml every 6 hours for 96 hours
Placebo: 5% Dextrose in water: Placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Receptor for Advanced Glycation Endpoints at Study Hour 0, 48, 96, 168</title>
          <population>3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient</population>
          <units>ng/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="84"/>
                <count group_id="O2" value="83"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>0 hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6" spread="5"/>
                    <measurement group_id="O2" value="7" spread="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" spread="4"/>
                    <measurement group_id="O2" value="4" spread="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" spread="3"/>
                    <measurement group_id="O2" value="3" spread="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>168 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" spread="2"/>
                    <measurement group_id="O2" value="2" spread="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Tissue Factor Pathway Inhibitor at Study Hour 0, 48, 96, 168</title>
        <time_frame>Up to hour 168</time_frame>
        <population>3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient</population>
        <group_list>
          <group group_id="O1">
            <title>Ascorbic Acid</title>
            <description>200mg/kg/day divided over 4 doses. Administered every 6 hours for 96 hours
Ascorbic Acid: Intervention</description>
          </group>
          <group group_id="O2">
            <title>5% Dextrose in Water</title>
            <description>50ml every 6 hours for 96 hours
Placebo: 5% Dextrose in water: Placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Tissue Factor Pathway Inhibitor at Study Hour 0, 48, 96, 168</title>
          <population>3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient</population>
          <units>ng/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="84"/>
                <count group_id="O2" value="83"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>0 hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46" spread="35"/>
                    <measurement group_id="O2" value="43" spread="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42" spread="31"/>
                    <measurement group_id="O2" value="42" spread="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42" spread="27"/>
                    <measurement group_id="O2" value="44" spread="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>168 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44" spread="34"/>
                    <measurement group_id="O2" value="42" spread="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Oxygenation Score: Pressure</title>
        <description>Oxygenation as measure by the ratio of arterial oxygen partial pressure to fractional inspired oxygen (PaO2/FiO2). Scores range from 100 to 300 with lower values indicating more worse outcomes</description>
        <time_frame>Up to hour 168</time_frame>
        <population>3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient</population>
        <group_list>
          <group group_id="O1">
            <title>Ascorbic Acid</title>
            <description>200mg/kg/day divided over 4 doses. Administered every 6 hours for 96 hours
Ascorbic Acid: Intervention</description>
          </group>
          <group group_id="O2">
            <title>5% Dextrose in Water</title>
            <description>50ml every 6 hours for 96 hours
Placebo: 5% Dextrose in water: Placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Oxygenation Score: Pressure</title>
          <description>Oxygenation as measure by the ratio of arterial oxygen partial pressure to fractional inspired oxygen (PaO2/FiO2). Scores range from 100 to 300 with lower values indicating more worse outcomes</description>
          <population>3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient</population>
          <units>mm Mercury</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="84"/>
                <count group_id="O2" value="83"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>0 hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="189" spread="96"/>
                    <measurement group_id="O2" value="214" spread="183"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="233" spread="115"/>
                    <measurement group_id="O2" value="246" spread="105"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="226" spread="109"/>
                    <measurement group_id="O2" value="244" spread="122"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>168 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="233" spread="134"/>
                    <measurement group_id="O2" value="254" spread="145"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Oxygenation Score: Saturation</title>
        <description>Oxygenation as measure by the ratio of arterial oxygen saturation to fraction of inspired oxygen SpO2/FiO2</description>
        <time_frame>Up to hour 168</time_frame>
        <population>3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient</population>
        <group_list>
          <group group_id="O1">
            <title>Ascorbic Acid</title>
            <description>200mg/kg/day divided over 4 doses. Administered every 6 hours for 96 hours
Ascorbic Acid: Intervention</description>
          </group>
          <group group_id="O2">
            <title>5% Dextrose in Water</title>
            <description>50ml every 6 hours for 96 hours
Placebo: 5% Dextrose in water: Placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Oxygenation Score: Saturation</title>
          <description>Oxygenation as measure by the ratio of arterial oxygen saturation to fraction of inspired oxygen SpO2/FiO2</description>
          <population>3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient</population>
          <units>Ratio</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="84"/>
                <count group_id="O2" value="83"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>0 hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="168" spread="51"/>
                    <measurement group_id="O2" value="177" spread="106"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="231" spread="81"/>
                    <measurement group_id="O2" value="220" spread="75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="250" spread="101"/>
                    <measurement group_id="O2" value="244" spread="88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>168 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="268" spread="107"/>
                    <measurement group_id="O2" value="299" spread="115"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Coagulation</title>
        <description>Coagulation as measured by Platelets per unit of blood. Scores range from less than 20 to more than 150. Lower scores indicate worse outcomes</description>
        <time_frame>Up to hour 168</time_frame>
        <population>3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient</population>
        <group_list>
          <group group_id="O1">
            <title>Ascorbic Acid</title>
            <description>200mg/kg/day divided over 4 doses. Administered every 6 hours for 96 hours
Ascorbic Acid: Intervention</description>
          </group>
          <group group_id="O2">
            <title>5% Dextrose in Water</title>
            <description>50ml every 6 hours for 96 hours
Placebo: 5% Dextrose in water: Placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Coagulation</title>
          <description>Coagulation as measured by Platelets per unit of blood. Scores range from less than 20 to more than 150. Lower scores indicate worse outcomes</description>
          <population>3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient</population>
          <units>Platelets/uL of Blood</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="84"/>
                <count group_id="O2" value="83"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>0 hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="173" spread="123"/>
                    <measurement group_id="O2" value="175" spread="142"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="171" spread="133"/>
                    <measurement group_id="O2" value="147" spread="115"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="182" spread="141"/>
                    <measurement group_id="O2" value="165" spread="119"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>168 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="226" spread="180"/>
                    <measurement group_id="O2" value="228" spread="127"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Liver Function</title>
        <description>Liver function as measured by Total Bilirubin. Normal levels range from 0.2 - 1.2. Levels greater than 1.2 indicate worse outcomes</description>
        <time_frame>Up to hour 168</time_frame>
        <population>3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient</population>
        <group_list>
          <group group_id="O1">
            <title>Ascorbic Acid</title>
            <description>200mg/kg/day divided over 4 doses. Administered every 6 hours for 96 hours
Ascorbic Acid: Intervention</description>
          </group>
          <group group_id="O2">
            <title>5% Dextrose in Water</title>
            <description>50ml every 6 hours for 96 hours
Placebo: 5% Dextrose in water: Placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Liver Function</title>
          <description>Liver function as measured by Total Bilirubin. Normal levels range from 0.2 - 1.2. Levels greater than 1.2 indicate worse outcomes</description>
          <population>3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient</population>
          <units>Mg/dL</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="84"/>
                <count group_id="O2" value="83"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>0 hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0" upper_limit="22"/>
                    <measurement group_id="O2" value="1" lower_limit="0" upper_limit="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0" upper_limit="23"/>
                    <measurement group_id="O2" value="1" lower_limit="0" upper_limit="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0" upper_limit="22"/>
                    <measurement group_id="O2" value="1" lower_limit="0" upper_limit="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>168 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0" upper_limit="28"/>
                    <measurement group_id="O2" value="1" lower_limit="0" upper_limit="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cardiovascular Function</title>
        <description>Cardiovascular function as measured by Mean arterial pressure. Scores less than 70 mmHg indicate worse outcomes.</description>
        <time_frame>Up to hour 168</time_frame>
        <population>3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient</population>
        <group_list>
          <group group_id="O1">
            <title>Ascorbic Acid</title>
            <description>200mg/kg/day divided over 4 doses. Administered every 6 hours for 96 hours
Ascorbic Acid: Intervention</description>
          </group>
          <group group_id="O2">
            <title>5% Dextrose in Water</title>
            <description>50ml every 6 hours for 96 hours
Placebo: 5% Dextrose in water: Placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Cardiovascular Function</title>
          <description>Cardiovascular function as measured by Mean arterial pressure. Scores less than 70 mmHg indicate worse outcomes.</description>
          <population>3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient</population>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="84"/>
                <count group_id="O2" value="83"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>0 hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73" spread="13"/>
                    <measurement group_id="O2" value="73" spread="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78" spread="15"/>
                    <measurement group_id="O2" value="79" spread="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84" spread="16"/>
                    <measurement group_id="O2" value="84" spread="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>168 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81" spread="14"/>
                    <measurement group_id="O2" value="83" spread="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>State of Consciousness</title>
        <description>State of consciousness as measure by Glasgow Coma Scale which gives a score based on eye, verbal, and motor responses. Scores range from 3 to 15 with lower scores indicating worse outcome</description>
        <time_frame>Up to hour 168</time_frame>
        <population>3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient</population>
        <group_list>
          <group group_id="O1">
            <title>Ascorbic Acid</title>
            <description>200mg/kg/day divided over 4 doses. Administered every 6 hours for 96 hours
Ascorbic Acid: Intervention</description>
          </group>
          <group group_id="O2">
            <title>5% Dextrose in Water</title>
            <description>50ml every 6 hours for 96 hours
Placebo: 5% Dextrose in water: Placebo</description>
          </group>
        </group_list>
        <measure>
          <title>State of Consciousness</title>
          <description>State of consciousness as measure by Glasgow Coma Scale which gives a score based on eye, verbal, and motor responses. Scores range from 3 to 15 with lower scores indicating worse outcome</description>
          <population>3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient</population>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="84"/>
                <count group_id="O2" value="83"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>0 hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8" lower_limit="2" upper_limit="15"/>
                    <measurement group_id="O2" value="7" lower_limit="3" upper_limit="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9" lower_limit="3" upper_limit="15"/>
                    <measurement group_id="O2" value="9" lower_limit="3" upper_limit="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10" lower_limit="3" upper_limit="15"/>
                    <measurement group_id="O2" value="10" lower_limit="3" upper_limit="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>168 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10" lower_limit="3" upper_limit="15"/>
                    <measurement group_id="O2" value="12" lower_limit="3" upper_limit="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Renal Function</title>
        <description>Renal function as measured by Creatinine. Scores range from less than 1.2 to greater than 5.0 with higher scores indicating worse outcomes</description>
        <time_frame>Up to hour 168</time_frame>
        <population>3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient</population>
        <group_list>
          <group group_id="O1">
            <title>Ascorbic Acid</title>
            <description>200mg/kg/day divided over 4 doses. Administered every 6 hours for 96 hours
Ascorbic Acid: Intervention</description>
          </group>
          <group group_id="O2">
            <title>5% Dextrose in Water</title>
            <description>50ml every 6 hours for 96 hours
Placebo: 5% Dextrose in water: Placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Renal Function</title>
          <description>Renal function as measured by Creatinine. Scores range from less than 1.2 to greater than 5.0 with higher scores indicating worse outcomes</description>
          <population>3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient</population>
          <units>Mg/dL</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="84"/>
                <count group_id="O2" value="83"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>0 hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0" upper_limit="6"/>
                    <measurement group_id="O2" value="2" lower_limit="0" upper_limit="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="0" upper_limit="8"/>
                    <measurement group_id="O2" value="1" lower_limit="0" upper_limit="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0" upper_limit="7"/>
                    <measurement group_id="O2" value="1" lower_limit="0" upper_limit="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>168 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0" upper_limit="7"/>
                    <measurement group_id="O2" value="1" lower_limit="0" upper_limit="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>All-cause mortality was collected for all days in the ICU, up to 4 days</time_frame>
      <desc>Due to the high level of adverse events normally associated with patients experiencing Sepsis Induced Acute Lung Injury, other than mortality, only drug related adverse events were tracked.</desc>
      <group_list>
        <group group_id="E1">
          <title>Ascorbic Acid</title>
          <description>200mg/kg/day divided over 4 doses. Administered every 6 hours for 96 hours
Ascorbic Acid: Intervention</description>
        </group>
        <group group_id="E2">
          <title>5% Dextrose in Water</title>
          <description>50ml every 6 hours for 96 hours
Placebo: 5% Dextrose in water: Placebo</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="25" subjects_at_risk="84"/>
                <counts group_id="E2" subjects_affected="38" subjects_at_risk="83"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="83"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="83"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Alpha A Fowler, III, MD</name_or_title>
      <organization>Virginia Commonwealth University School of Medicine</organization>
      <phone>804-828-9071</phone>
      <email>alpha.fowler@vcuhealth.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

